Ovarian Cancer
Ovarian Steroid Cell Tumor
Female, 43 years
Patient Internal ID 67139659
ICD-10 code
C56 Malignant Neoplasm of Ovary
Diagnosis (Incl. Metastases/Stage) and Year
February 2015
Ovarian Steroid Cell Tumor Stage IC. Peritoneal Metastases (2016), Metastases in the Pelvis (2017, 2018, 2019). Metastases in the Lungs (2020).
Previous Treatment
Surgery (Salpingo-oophorectomy), Surgery (Total Hysterectomy, Salpingo-oophorectomy, Omentectomy), Chemotherapy (Carboplatin and Paclitaxel), Surgery (Abdominal Hernia Repair), Chemotherapy (Cisplatin and Etoposide), Chemotherapy (Carboplatin and Paclitaxel), Chemotherapy (Docetaxel), Hormone Therapy (Goserelin), Immunotherapy (Bevacizumab).
Prognosis and Survival Expectation
Metastatic Malignant Steroid Cell Tumors are very rare and survival rates vary between cases. Some literature reports of 6-11 months after disease recurrence.
Treatment Provided
Autologous DCV (7 doses) and CIK (4 doses) over a period of 6 months.
Patient Survival/Condition and Year
Date of Review: 06/12/2023
The patient has survived for 71 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Surgeries, Chemotherapy and Hormone Therapy, has benefited patient in disease stabilisation and extended survival.
